Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/Net Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Net Sales(x) 4.113.667.217.334.94

What is the latest EV/Net Sales ratio of NATCO PHARMA ?

The latest EV/Net Sales ratio of NATCO PHARMA is 4.11 based on Mar2024 Consolidated results.
Year EV/Net Sales
Mar20244.11
Mar20233.66
Mar20227.21
Mar20217.33
Mar20204.94

How is EV/Net Sales of NATCO PHARMA Trending?

Years EV/Net Sales % Change
Mar2024 4.11
12.30
Mar2023 3.66
-49.24
Mar2022 7.21
-1.64
Mar2021 7.33
48.38
Mar2020 4.94 -

Other Financial Ratios of NATCO PHARMA


Compare EV/Net Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,823.5 Cr 4.5% 7.1% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.5%

7.1%

-11.6%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses